Skip to main content

Lysosomal Acid Lipase (LAL) Deficiency

CPT 82657
Synonyms
  • Cholesteryl Ester Storage Disease (CESD)
  • Wolman Disease

Test Details

Methodology

Determination of enzyme activity against 4-methylumbelliferyl-palmitate

Result Turnaround Time

3 - 14 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

For more information, please view the literature below.

Lysosomal Acid Lipase Deficiency Testing

Use

Diagnose Wolman disease and cholesteryl ester storage disease (CESD) caused by LAL deficiency.

Special Instructions

When submitting whole blood, specimen must arrive at the testing laboratory within 4 days of collection.

Limitations

This test is not appropriate for determination of carrier status, as some clinical conditions may result in indeterminate enzyme activity levels.

This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).

Specimen Requirements

Specimen

Whole blood (EDTA) or dried blood spot

Volume

3 mL whole blood or two circles dried blood spot

Minimum Volume

1 mL whole blood or one circle dried blood spot

Container

Lavender-top (EDTA) or tan-top (EDTA) tube (whole blood) or Whatman Protein Saver Card 903 (dried blood spot)

Storage Instructions

Whole blood: Refrigerated transport must arrive at testing facility within 4 days of collection. Dried blood spot: Maintain specimen at room temperature.

Causes for Rejection

Whole blood: Pink top EDTA tubes, anticoagulant other than EDTA, specimen clotted; gross hemolysis; frozen specimen. Dried blood spot: Clotted; gross hemolysis; sample not properly dried; serum separated from cells.

References

Hamilton J, Jones I, Srivastava R, Galloway P. A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2. Clin Chim Acta. 2012 Aug 16; 413(15-16):1207-1210. 22483793

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
402300 Lysosomal Acid Lipase Def 76615-4 402301 Specimen Type: 31208-2
402300 Lysosomal Acid Lipase Def 76615-4 402307 LAL Activity pmol/hr/punch 76615-4
402300 Lysosomal Acid Lipase Def 76615-4 402303 Interpretation: 69426-5
402300 Lysosomal Acid Lipase Def 76615-4 402304 Director Review: 72486-4
402300 Lysosomal Acid Lipase Def 76615-4 402305 Methodology 49549-9
402300 Lysosomal Acid Lipase Def 76615-4 402308 Disclaimer: N/A
Order Code402300
Order Code NameLysosomal Acid Lipase Def
Order Loinc76615-4
Result Code402301
Result Code NameSpecimen Type:
UofM
Result LOINC31208-2
Order Code402300
Order Code NameLysosomal Acid Lipase Def
Order Loinc76615-4
Result Code402307
Result Code NameLAL Activity
UofMpmol/hr/punch
Result LOINC76615-4
Order Code402300
Order Code NameLysosomal Acid Lipase Def
Order Loinc76615-4
Result Code402303
Result Code NameInterpretation:
UofM
Result LOINC69426-5
Order Code402300
Order Code NameLysosomal Acid Lipase Def
Order Loinc76615-4
Result Code402304
Result Code NameDirector Review:
UofM
Result LOINC72486-4
Order Code402300
Order Code NameLysosomal Acid Lipase Def
Order Loinc76615-4
Result Code402305
Result Code NameMethodology
UofM
Result LOINC49549-9
Order Code402300
Order Code NameLysosomal Acid Lipase Def
Order Loinc76615-4
Result Code402308
Result Code NameDisclaimer:
UofM
Result LOINCN/A